Axa S.A. Alx Oncology Holdings Inc Transaction History

Axa S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.89 - $19.46 $731,532 - $2.42 Million	-124,199 Closed	0 $0
Q1 2022 Feb 14, 2023	BUY	$13.65 - $22.06 $1.7 Million - $2.74 Million	124,199 New	124,199 $2.1 Million
Q1 2022 May 13, 2022	BUY	$13.65 - $22.06 $13 - $22	1 Added 0.0%	124,199 $2.1 Million
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $294,520 - $1.02 Million	13,705 Added 12.4%	124,198 $2.67 Million
Q3 2021 Nov 15, 2021	BUY	$52.51 - $80.91 $213,768 - $329,384	4,071 Added 3.83%	110,493 $8.16 Million
Q2 2021 Aug 13, 2021	BUY	$52.2 - $75.23 $611,992 - $881,996	11,724 Added 12.38%	106,422 $5.82 Million
Q1 2021 May 14, 2021	BUY	$62.84 - $87.68 $717,632 - $1 Million	11,420 Added 13.71%	94,698 $6.98 Million
Q4 2020 Feb 12, 2021	BUY	$34.11 - $112.26 $287,444 - $946,015	8,427 Added 11.26%	83,278 $7.18 Million
Q3 2020 Nov 13, 2020	BUY	$29.36 - $47.1 $2.2 Million - $3.53 Million	74,851 New	74,851 $2.83 Million

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.